Geri
Starpharma Holdings Ltd (SPHRY) Fiyatı
SPHRY Hisse Senedi Fiyat Grafiği
SPHRY Finansal
Starpharma Holdings Ltd
$2.3
-11.53%
$-0.3
Kapanışta: Jan 16, 16:00:00 GMT-5
$2.3
0%
$0
Sonrası Piyasa: Jan 16, 20:00:00 GMT-5
Önemli İstatistikler
Önceki Kapanış
$2.6
Açılış fiyatı
$2.3
Günün Aralığı
$2.3 - $2.3
52 haftalık aralık
$0.47 - $2.86
İşlem hacmi
1.1K
Ort.Hacim
1.0K
EPS (TTM)
-0.16
Dividend yield
--
Piyasa Değeri
$96.1M
SPHRY nedir?
Starpharma Holdings Ltd. engages in the research, development, and commercialization of dendrimer products for pharmaceutical and healthcare applications. The firm's principal activities are focused on the research, development and commercialization of dendrimer technology for pharmaceutical and healthcare applications. The firm's portfolio of dendrimer-based products includes three clinical-stage dendrimer enhanced product (DEP) assets, preclinical radiopharmaceutical assets, research collaborations, and three commercially marketed over the counter (OTC) products. Its clinical-stage assets, DEP SN38, DEP cabazitaxel, and DEP docetaxel, are dendrimer-based chemotherapeutic drugs. Additionally, the Company has a preclinical pipeline of DEP radiopharmaceuticals in development. The company also manufactures and sells SPL7013 (astodrimer sodium) proprietary products: VivaGel BV, Viraleze nasal spray, and VivaGel condom. The firm has applied its DEP technology to the innovative area of antibody-drug conjugates.
Özellikler
Ticaret Stratejileri
Kaynaklar
© 2025 Finture Development Limited. All rights reserved